Cromwell Holdings LLC Increases Stake in CVS Health Corporation $CVS

Cromwell Holdings LLC increased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 244.3% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 3,185 shares of the pharmacy operator’s stock after purchasing an additional 2,260 shares during the period. Cromwell Holdings LLC’s holdings in CVS Health were worth $220,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in CVS. Vanguard Group Inc. raised its holdings in shares of CVS Health by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator’s stock valued at $8,017,223,000 after purchasing an additional 969,027 shares in the last quarter. Dodge & Cox lifted its holdings in CVS Health by 4.8% during the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock worth $4,976,856,000 after buying an additional 3,353,223 shares during the last quarter. Invesco Ltd. lifted its holdings in CVS Health by 13.2% during the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator’s stock worth $1,383,039,000 after buying an additional 2,375,764 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in CVS Health by 14.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,309,289 shares of the pharmacy operator’s stock worth $1,037,205,000 after buying an additional 1,942,886 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in CVS Health by 5.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator’s stock worth $924,643,000 after buying an additional 728,924 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.22% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the subject of a number of recent analyst reports. Bernstein Bank decreased their price target on CVS Health from $78.00 to $72.00 and set a “market perform” rating for the company in a report on Wednesday, July 16th. Sanford C. Bernstein increased their target price on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. Robert W. Baird raised shares of CVS Health from a “neutral” rating to an “outperform” rating and increased their target price for the company from $71.00 to $82.00 in a research report on Thursday, August 14th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $78.00 target price on shares of CVS Health in a research report on Tuesday, August 26th. Finally, UBS Group raised shares of CVS Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $67.00 to $79.00 in a research report on Monday, August 18th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $78.25.

CVS Health Trading Up 0.8%

Shares of CVS Health stock opened at $77.48 on Friday. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $77.76. The company has a market capitalization of $98.27 billion, a P/E ratio of 21.64, a PEG ratio of 0.85 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The company’s fifty day moving average is $70.37 and its two-hundred day moving average is $67.27.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company had revenue of $98.92 billion during the quarter, compared to analysts’ expectations of $94.87 billion. During the same quarter last year, the business earned $1.83 EPS. The business’s revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.